Company Active LTD

Company profile

Astrimmune Ltd

Astrimmune Ltd is a UK company with status active founded in 2011 based in East Midlands.

CRN
07880369
Founded
2011
Age
14

Overview

Legal name
ASTRIMMUNE LTD
Region
East Midlands
Registered address
24 BUCKINGHAM ROAD
SANDIACRE
NOTTINGHAM
ENGLAND
NG10 5PP
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2023 to 31 Mar 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

19 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

05 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

18 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MDA3MjE5OWFkaXF6a2N4

Published 18 Oct 2024 12:25

13 Dec
2011

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2015
Funded years
2015, 2017
Age at first award
3 years

Projects

2017 Feasibility Studies

A novel instrument for the analysis of urine for the nonA novel instrument for the analysis of urine for the non-invasive detection of bladder cancer-invasive detection of bladder cancer

1 Oct 2017 to 30 Jun 2018

Awarded
£24,766
Total cost £35,380

Can we detect and monitor bladder cancer with a urine test? For many patients with bladder cancer (BC), their cancer comes back after treatment and so they have to be regularly checked. These patients are checked with a cystoscope. This is a long thin flexible tube with a light and a camera at the end that is inserted into the urethra (the tube that carri...

2017 Collaborative R&D Lead participant

Enabling UV Analysis of Circulating Tumour Cells

1 Jun 2017 to 31 Mar 2018

Awarded
£12,500
Total cost £12,500

We urgently need earlier detection of cancer and other diseases. Earlier detection leads to lower costs, better survival and higher quality of patient life by allowing earlier and more effective treatment options. Astrimmune responded to this challenge with an advanced filter product that allows the isolation of circulating tumour cells and other rare cel...

2015 SME Support Lead participant

Astrimmune Ltd (ADD ON to 131951)

1 Dec 2015 to 29 Feb 2016

Awarded
£600
Total cost £600

Astrimmune has developed Fluid-Flow Cell-Imaging as a non-invasive general cancer screen. We produce multiple label-free or labeled, moving and static images of cells in blood or urine. Images are created in different ways and consolidated using Astronomical Algorithms that have been applied to images of distant galaxies. When a suspicious cell is found w...

2015 Feasibility Studies Lead participant

Concept Evaluation of a Cellular-Digital Phenotypic Diagnostic PCR Platform

1 Jun 2015 to 30 Sep 2015

Awarded
£23,100
Total cost £33,000

Digital technology has transformed the IT, communications, entertainment industries and social media and continues to make impressive inroads in medical diagnostics. We have conceived of a novel digital technique applied to the analysis of human blood in order to detect cancer at an earlier stage and to allow doctors to take better infomred, appropriate a...

Product types

Collaborative R&D Feasibility Studies SME Support